CardioNet Defies Prior Secondary Trends (BEAT)

Cardionet_logoCardioNet, Inc. (NASDAQ: BEAT) is holding up rather well considering the discount pricing of a secondary offering.  The company sold 5 million shares at a price of $26.50 per share.  All shares were being sold by selling shareholders and the company itself will realize no proceeds from the sale of these shares. 

Citigroup was the sole book-runner and co-managers were Banc ofAmerica, Leerink Swann, Thomas Weisel, and Cowen & Co. Shares areup at $28.19 today on more than 1.2 million shares.  This stock hastraded between $26 and $30 for almost all of the last month and shareswere under $20.00 back in April.

Hmm.  Insiders and backers selling after a large run when the markethas been challenged.  That’s not necessarily a red flag but it also isn’t exactly aringing endorsement for tomorrow.  Usually this much discounting for a secondary where the company gets no benefit after a large run up has more consequences.  Perhaps the company’s niche is offering it some protection.

Jon C. Ogg
August 1, 2008